Evaluating representation learning on the protein structure universe
Authors:
Arian R. Jamasb,
Alex Morehead,
Chaitanya K. Joshi,
Zuobai Zhang,
Kieran Didi,
Simon V. Mathis,
Charles Harris,
Jian Tang,
Jianlin Cheng,
Pietro Lio,
Tom L. Blundell
Abstract:
We introduce ProteinWorkshop, a comprehensive benchmark suite for representation learning on protein structures with Geometric Graph Neural Networks. We consider large-scale pre-training and downstream tasks on both experimental and predicted structures to enable the systematic evaluation of the quality of the learned structural representation and their usefulness in capturing functional relations…
▽ More
We introduce ProteinWorkshop, a comprehensive benchmark suite for representation learning on protein structures with Geometric Graph Neural Networks. We consider large-scale pre-training and downstream tasks on both experimental and predicted structures to enable the systematic evaluation of the quality of the learned structural representation and their usefulness in capturing functional relationships for downstream tasks. We find that: (1) large-scale pretraining on AlphaFold structures and auxiliary tasks consistently improve the performance of both rotation-invariant and equivariant GNNs, and (2) more expressive equivariant GNNs benefit from pretraining to a greater extent compared to invariant models. We aim to establish a common ground for the machine learning and computational biology communities to rigorously compare and advance protein structure representation learning. Our open-source codebase reduces the barrier to entry for working with large protein structure datasets by providing: (1) storage-efficient dataloaders for large-scale structural databases including AlphaFoldDB and ESM Atlas, as well as (2) utilities for constructing new tasks from the entire PDB. ProteinWorkshop is available at: github.com/a-r-j/ProteinWorkshop.
△ Less
Submitted 19 June, 2024;
originally announced June 2024.
Utilising Graph Machine Learning within Drug Discovery and Development
Authors:
Thomas Gaudelet,
Ben Day,
Arian R. Jamasb,
Jyothish Soman,
Cristian Regep,
Gertrude Liu,
Jeremy B. R. Hayter,
Richard Vickers,
Charles Roberts,
Jian Tang,
David Roblin,
Tom L. Blundell,
Michael M. Bronstein,
Jake P. Taylor-King
Abstract:
Graph Machine Learning (GML) is receiving growing interest within the pharmaceutical and biotechnology industries for its ability to model biomolecular structures, the functional relationships between them, and integrate multi-omic datasets - amongst other data types. Herein, we present a multidisciplinary academic-industrial review of the topic within the context of drug discovery and development…
▽ More
Graph Machine Learning (GML) is receiving growing interest within the pharmaceutical and biotechnology industries for its ability to model biomolecular structures, the functional relationships between them, and integrate multi-omic datasets - amongst other data types. Herein, we present a multidisciplinary academic-industrial review of the topic within the context of drug discovery and development. After introducing key terms and modelling approaches, we move chronologically through the drug development pipeline to identify and summarise work incorporating: target identification, design of small molecules and biologics, and drug repurposing. Whilst the field is still emerging, key milestones including repurposed drugs entering in vivo studies, suggest graph machine learning will become a modelling framework of choice within biomedical machine learning.
△ Less
Submitted 10 February, 2021; v1 submitted 9 December, 2020;
originally announced December 2020.